Print
AVEG 006X; VEU 006
NCT00001020
Trial Details:
Phase:
I
Status:
Completed
Organizer developer:
National Institute of Allergy and Infectious Diseases (NIAID)
Start Date:
Product:
MN rgp120
Antigen:
Prime 1:
Prime Class:
Boost 1:
RandD/trials/Lists/ClinicalTrialsList
Boost 1 class:
Boost 2:
Boost 2 Class:
Boost 3:
Boost 3 Class:
Adjuvant:
Country:
Volunteers:
Env gp120 B
ClinicalTrials.gov Identifier:
Link: